Shots:
- Just-Evotec Biologics (Evotec’s biologics segment) & Sandoz have expanded their tech collaboration to develop & manufacture biosimilars. They have been in a multi-year tech collaboration since May 2023
- Under the agreement, Just-Evotec will get payment for early scientific validation along with additional funding tied to milestones from 2025
- Through the expanded collaboration, Just-Evotec will provide biosimilar to Sandoz from its new J.POD facility. Sandoz further gets long-term supply guarantees with significant reserved manufacturing capacity
Ref: Just-Evotec Biologics and Sandoz | Image: Just-Evotec Biologics and Sandoz| Press Release
Related News:- Fresenius Kabi Introduces Tyenne (Biosimilar, Actemra) Across the US
PharmaShots! Your go-to media platform for customized news ranging for multiple indications. For more information connect with us at connect@pharmashots.com
